ATRI Atrion Corporation

Atrion Reports Second Quarter Results

Atrion Reports Second Quarter Results

ALLEN, Texas, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced that for the second quarter ended June 30, 2020, revenues totaled $38.0 million compared with $40.1 million for the same period in 2019. Net income for the second quarter of 2020 totaled $8.6 million as compared to $9.7 million for the same period in 2019, with diluted earnings per share for the second quarter of 2020 at $4.68 compared to $5.18 for the second quarter of 2019.

Commenting on the Company’s quarterly results for the second quarter of 2020 compared to the same period last year, David A. Battat, President & CEO, stated, “The impact of the pandemic was felt in the second quarter with revenues and operating income lower by 5% and 8%, respectively, essentially the reverse image of the first quarter when revenues were up 5% and operating income was up 6%.” Mr. Battat explained, “The current year second quarter saw hospitals suspend elective surgeries to preserve ICU beds and other resources to deal with the anticipated deluge of Covid-19 patients. As a result, sales of our products used in elective procedures were lower by $3.7 million.” Mr. Battat added, “The net impact on overall sales was limited to $2.1 million thanks to our diversified product portfolio and the tireless efforts of my co-workers who kept our operations running throughout this period.” 

Mr. Battat continued “With an effective tax rate 15% higher in this year’s quarter than the prior year’s second quarter, diluted EPS and net income were lower by 10% and 11%, respectively. During the quarter we purchased 12,158 shares of our common stock at an average cost of $641 per share. As of June 30, 2020, we continue to be debt free while holding $87.5 million in cash and short and long term investments.”

Atrion Corporation develops and manufactures products primarily for medical applications. The Company’s website is



ATRION CORPORATION

UNAUDITED CONSOLIDATED STATEMENTS OF INCOME

(In thousands, except per share data)

 Three Months Ended

June 30,
 Six Months Ended

June 30,
  2020   2019   2020   2019 
Revenues$  37,968  $  40,103  $  81,563  $  81,717 
Cost of goods sold   20,499     21,511     44,226     44,422 
  Gross profit   17,469     18,592     37,337     37,295 
Operating expenses   7,423     7,626     15,577     15,291 
  Operating income   10,046     10,966     21,760     22,004 
        
Interest and dividend income   367     581       858       1,163 
Other investment income (loss)     354       161       (673)      372 
Income before income taxes   10,767     11,708     21,945     23,539 
Income tax provision   (2,162)    (2,044)    (4,443)    (4,437)
  Net income$    8,605  $    9,664  $17,502  $19,102 
        
Income per basic share$    4.69  $    5.21  $    9.49  $    10.30 
        
Weighted average basic shares   outstanding   1,835     1,854     1,844     1,854 
        
        
Income per diluted share$    4.68  $    5.18  $    9.47  $    10.25 
        
Weighted average diluted shares   outstanding   1,839     1,864     1,849     1,863 

                   



ATRION CORPORATION

CONSOLIDATED BALANCE SHEETS

(In thousands)

 June 30, Dec. 31,
ASSETS 2020  2019
 (Unaudited)  
Current assets:   
  Cash and cash equivalents$  24,099 $  45,048
  Short-term investments   6,574    23,766
    Total cash and short-term investments   30,673    68,814
  Accounts receivable   22,441    18,886
  Inventories   45,805    42,093
  Prepaid expenses and other   3,226    2,545
    Total current assets   102,145    132,338
 



Long-term investments
   56,871    31,772
 



Property, plant and equipment, net
   87,867    84,606
Other assets   13,467    13,315
    
 $  260,350 $  262,031
    
    
LIABILITIES AND STOCKHOLDERS’ EQUITY   
    
Current liabilities   15,443    11,274
Line of credit   --    --
Other non-current liabilities   11,380    12,887
Stockholders’ equity   233,527    237,870
    
 $  260,350 $  262,031

Contact:    

Jeffery Strickland

Vice President and Chief Financial Officer

(972) 390-9800

EN
06/08/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Atrion Corporation

 PRESS RELEASE

Atrion Reports Second Quarter 2024 Results

Atrion Reports Second Quarter 2024 Results ALLEN, Texas, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the second quarter ended June 30, 2024. Revenues for the second quarter of 2024 totaled $48.8 million compared to $43.8 million for the same period in 2023. For the just ended quarter, operating income was $0.5 million, down $6.8 million from the comparable 2023 period, and net income was $0.4 million, down $6.2 million from the same period in 2023. Operating income was significantly impacted by the accrual of $5.0 million in ac...

 PRESS RELEASE

Atrion Corporation Enters Into Merger Agreement with Nordson Corporati...

Atrion Corporation Enters Into Merger Agreement with Nordson Corporation ALLEN, Texas, May 28, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI), a developer and manufacturer of products primarily for medical applications, today announced that it has entered into an agreement and plan of merger with Nordson Corporation pursuant to which Nordson will acquire Atrion for $460 per share in cash, representing a total equity value of approximately $815 million. The transaction enterprise value reflects a multiple of 20.2 times Atrion’s 2023 EBITDA, and the $460 per share price represen...

 PRESS RELEASE

Atrion Corporation Declares Quarterly Cash Dividend

Atrion Corporation Declares Quarterly Cash Dividend ALLEN, Texas, May 21, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced that its Board of Directors declared a quarterly dividend of $2.20 per share on its outstanding shares of Common Stock. This dividend will be payable on June 28, 2024 to stockholders of record at the close of business on June 14, 2024. Atrion Corporation develops and manufactures products primarily for medical applications. The Company’s website is Contact: Cindy FergusonVice President and Chief Financial Officer(972) 390-9800          ...

 PRESS RELEASE

Atrion Reports First Quarter 2024 Results

Atrion Reports First Quarter 2024 Results ALLEN, Texas, May 10, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the first quarter ended March 31, 2024. Revenues for the first quarter of 2024 totaled $47.3 million compared to $40.0 million for the same period in 2023. For the just ended quarter, operating income was $3.1 million, down $1.3 million from the comparable 2023 period, primarily due to a one-time inventory write-off, and net income was $2.8 million, down $0.7 million from the same period in 2023. First quarter 2024 diluted earnings per...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch